FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for a fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride, marketed by I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride

Snippet

ORIG AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE)